MedTrace Logo

Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume

NCT05701332 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-01-27

No results posted yet for this study

Summary

To evaluate the effects of local intravesical B.C.G and gemcitabine on semen quality and testicular volume.

Conditions

  • Urothelial Carcinoma Bladder
  • Sperm Count, Low
  • Testis; Fibrosis

Interventions

BIOLOGICAL

Bacillus Calmette Guerin

effect of local B.C.G and Gemcitabine on semen parametes and testicular volume

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed M Eltaher, professor · Professor . Dr

  • Hosny A Behnsawy, associate professor · Professor . Dr

  • Mohammed H Zarzour, lecturer · Dr

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-12-01
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05701332 on ClinicalTrials.gov